A Metabolomics-Based Screening Proposal for Colorectal Cancer
Colorectal cancer (CRC) is a high incidence disease, characterized by high morbidity and mortality rates. Early diagnosis remains challenging because fecal occult blood screening tests have performed sub-optimally, especially due to hemorrhoidal, inflammatory, and vascular diseases, while colonoscop...
Main Authors: | Jacopo Troisi, Maria Tafuro, Martina Lombardi, Giovanni Scala, Sean M. Richards, Steven J. K. Symes, Paolo Antonio Ascierto, Paolo Delrio, Fabiana Tatangelo, Carlo Buonerba, Biancamaria Pierri, Pellegrino Cerino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/2/110 |
Similar Items
-
Frequency of Positive Fecal Occult Blood Test in Patients with Cirrhosis
by: Faisal Khan, et al.
Published: (2024-12-01) -
Endoscopic Treatment of Solitary Colonic Ganglioneuroma
by: Toshio Arai, et al.
Published: (2020-01-01) -
Fecal occult blood testing in colorectal cancer screening programs
by: N. V. Severskaya, et al.
Published: (2022-09-01) -
Proportion and characteristics of screen-detected and non-screen-detected colorectal cancers in Germany
by: Michel Hornschuch, et al.
Published: (2024-11-01) -
Embedded Immunodetection System for Fecal Occult Blood
by: Kai-Wen Lin, et al.
Published: (2021-04-01)